This site uses cookies to improve user experience by collecting data. By continuing to use this website, you agree to the use of cookies and similar technologies as described in our Privacy Policy.
CONFIRM

ACC

Program
Discovery
Preclinical
Phase I
Phase II
ACE1702
HER2 Targeting, ACC-oNK Cell Therapy
Phase I ​
ACE1831
CD20 Targeting, ACC-NKγδT Cell Therapy
Preclinical ​
ACE1708
PD-L1 Targeting, ACC-NKγδT Cell Therapy
Preclinical ​
ACE1975
Target undisclosed, ACC-NKγδT Cell Therapy
Preclinical ​
ACE2023
Target undisclosed, ACC-NKγδT Cell Therapy
Preclinical ​
ACE2107
Target undisclosed
Discovery ​
ACE2146
Target undisclosed
Discovery ​
We have collaborated with biopharmaceutical partners and academic institutes worldwide.